Navigation Links
Aware, Inc. Reports Second Quarter 2009 Financial Results
Date:8/1/2009

BEDFORD, Mass., July 30 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, today reported financial results for its second quarter ended June 30, 2009.

Revenues for the second quarter of 2009 were $5.8 million, a decrease of 7% compared to $6.2 million in the same quarter last year. For the six months ended June 30, 2009, revenues decreased 14% to $10.3 million, compared to $12.0 million in the same period a year ago.

The Company reports its net income and basic and diluted net income per share in accordance with U.S. generally accepted accounting principles (GAAP), and additionally, on a non-GAAP basis. Non-GAAP net income, where applicable, excludes the effect of stock-based compensation expense. The company uses the non-GAAP information internally to evaluate its operating performance and believes these non-GAAP measures are useful to investors as they provide additional insight into the underlying operating results. However, non-GAAP measures are not stated in accordance with, should not be considered in isolation from, and are not a substitute for, GAAP measures. A reconciliation of GAAP to non-GAAP results has been provided in the attached financial tables.

The GAAP net loss for the second quarter of 2009 was $1.6 million, or $0.08 per diluted share, which included $0.4 million of stock-based compensation charges in accordance with the provisions of FAS 123(R). This compared to a GAAP net loss of $1.3 million, or $0.05 per diluted share, for the same period a year ago. GAAP net loss for the six months ended June 30, 2009 was $3.7 million, or $0.17 per share, compared to a net loss of $2.5 million, or $0.11 per share, for the same period a year ago.

The non-GAAP net loss for the second quarter
'/>"/>

SOURCE Aware, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Aware, Inc. Announces Q209 Earnings Conference Call
2. Aware, Inc. Reports First Quarter 2009 Financial Results
3. Aware, Inc. Reports First Quarter 2009 Financial Results
4. Aware, Inc. Announces Final Results of Dutch Auction Tender Offer
5. Aware, Inc. Announces Q1 09 Earnings Conference Call
6. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
7. Aware, Inc. Announces Preliminary Results of Dutch Auction Tender Offer
8. Aware, Inc. Amends and Extends Dutch Auction Tender Offer
9. Aware, Inc. Commences Dutch Auction Tender Offer
10. Aware, Inc. Commences Dutch Auction Tender Offer
11. Aware, Inc. Reports Fourth Quarter and 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...a group of University of Oklahoma researchers were...the human genome project. Today, the OU Advanced...n international effort to sequence the tomato geno...al Science Foundation for plant genomics. , "Th... improving the tomato and crop yields will improve...
(Date:11/20/2009)... DC Nov. 20, 2009) Scientists from the Marine Bi...of the Naval Research Laboratory (NRL) organized a...sts on an Arctic expedition to initiate methane hy...e the spatial variation of sediment contribution t...ast Guard Cutter Polar Sea as a research platform,...
(Date:11/20/2009)... Mass., November 19, 2009 The estimated 4.6 milli...e at risk of developing respiratory symptoms due t...questionnaire study undertaken earlier this year b...ool of Veterinary Medicine. , The studywhich pol...nd that 50 percent of individuals working in barns...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2International expedition investigates climate change, alternative fuels in Arctic 2Barn personnel experience higher-than-average rates of respiratory symptoms 2CMPI to Host Hill Briefing on Follow On Biologic Drugs for Media and Congressional Staff with Reps Eshoo and Rogers 51148 1CMPI to Host Hill Briefing on Follow On Biologic Drugs for Media and Congressional Staff with Reps Eshoo and Rogers 51148 2Statement About Agreement With White House and Senate Finance Committee on Health Reform 51145 1Statement About Agreement With White House and Senate Finance Committee on Health Reform 51145 2California Department of Public Health Reports Large Increase in Pet Euthanasia 51142 1California Department of Public Health Reports Large Increase in Pet Euthanasia 51142 2California Department of Public Health Reports Large Increase in Pet Euthanasia 51142 3
... AMES, Iowa -- Stress may indeed be a direct contr... new Iowa State University study finding that incr...ed with a greater likelihood of them being overwei...ged 10-15) and their mothers from low income famil...San Antonio -- was posted online by the Journal o...
... Oxford, UK, 14 May 2009 - A new article published...ww.elsevier.com/bihy ) suggests that our feelings ...labe Bucay suggests that a wide range of chemicals... moods could affect ,germ cells, (eggs and sperm),...tion. Such natural chemicals could affect the way ...
... Bacterial vaginosis (BV) is the most common vagin...is common in pregnant women. BV occurs when the no...d and replaced by an overgrowth of certain bacteri...k for a variety of complications, such as preterm ... how it can be prevented. Vitamin D may play a rol...
Other Biology News:Study finds link between individual stress and adolescent obesity 2Study finds link between individual stress and adolescent obesity 3Vitamin D insufficiency linked to bacterial vaginosis in pregnant women 2
(Date:11/20/2009)..., STOCKHOLM, November 20 Ka...uropean Investment Fund (EIF) has entered into a,c...vestment fund will be,managed by Karolinska Develo...o of early-stage pharmaceutical and medical techno...ros in the co-investment fund. The agreement,repre...
(Date:11/20/2009)... METTLER TOLEDO recently announced ...binar, “The Role of Process Analytical Techn...ng” on December 1, 2009. , ...he Role of Process Analytical Technology (PAT) in ...December 1, Process Analytical Technology (PAT) ca...
(Date:11/19/2009)... SEATTLE, Nov. 19 Omeros...dited financial results for the third quarter ende...eptember 30, 2009, Omeros reported a net loss of $...net loss of $7.4 million, or $2.54 per share, for ... September 30, 2009, the Company reported a net lo...
(Date:11/19/2009)... NEW YORK, Nov. 19 NeoSt...it has sent the following letter to its shareholde...er 30, 2009, of China Biopharmaceuticals Holdings,...pany based in the People,s Republic of China. The ... Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s prima...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...c.,(Nasdaq: MEDX ) is scheduled to announce its 2..., February 26, 2008 by press release after the,fin...arex,s management will host a conference call,and ...the call live, please,dial 1-866-510-0710 (U.S./Ca...passcode number 15176024. The webcast can be acces...
... compared to Q4 2006, to RMB45.7 ...me grew 152.2%, as compared to Q4 2006, to RMB17.9...- 2007 fiscal year net revenues increased 41.0% ye...lion (US$24.7 million),- 2007 fiscal year net inco... (US$11.2 million), SHENY...
...ion that causes iron to rust plays a similarly cor...away at healthy cells and is a process, scientists...conditions in humans ranging from Alzheimer,s, hea... process of aging. , Now, writing in the current ...eam of University of Wisconsin-Madison scientists ...
Other Biology Technology:Medarex to Announce 2007 Fourth Quarter and Year-End Financial Results on Tuesday, February 26, 2008 23SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 23SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 33SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 43SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 53SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 63SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 73SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 83SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 93SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 103SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 113SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 123SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 133SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 143SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 153SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results 16Genetic pathway critical to disease, aging found 2Genetic pathway critical to disease, aging found 3
...Research Registered OLAW Assured AAALAC Accredited...Certified Technicians Documentation GLP Process ... Focus CRP is your one stop shopping point for al...free project consultation, free peptide sequence r...
Rat Atriopeptin EIA Kit from Cayman Chemical
Homocystine ELISA Kit, Single from Bio-Quant Inc.
Brucella IgG ELISA Kit, Single from Bio-Quant Inc.
Biology Products: